Prospective Observational Study of Systemic Therapy for HCC in Japan: Exploratory Biomarker-Analysis
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000048298
- Lead Sponsor
- Investigator Initiated Study Promotion Center none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 193
Inclusion Criteria
Not provided
Exclusion Criteria
No particular setting
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To analyze some biomarkers of angiogenesis-related and tumor-immunity-related factors serially and to clarify the relationship of the biomarker with patient background, clinicopathological findings, treatment response (overall survival, progression-free survival, objective response rate, etc.), and adverse events.
- Secondary Outcome Measures
Name Time Method